ImmunoMethodsPub Date : 1993-10-01Epub Date: 2002-05-25DOI: 10.1006/immu.1993.1046
Ligler Frances S., Golden Joel P., Shriver-Lake Lisa C., Ogert Robert A., Wijesuria Daya, Anderson George P.
{"title":"Fiber-Optic Biosensor for the Detection of Hazardous Materials","authors":"Ligler Frances S., Golden Joel P., Shriver-Lake Lisa C., Ogert Robert A., Wijesuria Daya, Anderson George P.","doi":"10.1006/immu.1993.1046","DOIUrl":"10.1006/immu.1993.1046","url":null,"abstract":"<div><p>The fiber-optic biosensor combines evanescent wave sensing, fiber-optic technology, and fluorescence immunoassays to achieve a rapid, sensitive, and simple detection system. The response time varies from 2 to 15 min, depending on the type of assay performed. Sensitivity in the 1-10 ng/ml or 1000-cell range has been achieved. Fiber-optic biosensors can be adapted to detect the presence of toxic agents in a wide variety of samples.</p></div>","PeriodicalId":79341,"journal":{"name":"ImmunoMethods","volume":"3 2","pages":"Pages 122-127"},"PeriodicalIF":0.0,"publicationDate":"1993-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1006/immu.1993.1046","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51492911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ImmunoMethodsPub Date : 1993-10-01Epub Date: 2002-05-25DOI: 10.1006/immu.1993.1044
Bright Frank V., Wang Run, Li Ming, Dunbar Richard A.
{"title":"Probing the Dynamics of Surface-Immobilized Bioreceptors Using Picosecond Time-Resolved Spectroscopy","authors":"Bright Frank V., Wang Run, Li Ming, Dunbar Richard A.","doi":"10.1006/immu.1993.1044","DOIUrl":"10.1006/immu.1993.1044","url":null,"abstract":"<div><p>Total internal reflection fluorescence (TIRF) is used in concert with the multifrequency phase and modulation (MPM) technique to study <em>in situ</em> the interfacial distribution of surface-immobilized F(ab′) antifluorescein antibodies. Using this new technique we recover information on the surface-immobilized receptor dynamics and demonstrate that this particular immunosurface is composed of an unstable distribution of biodomains. The MPM-TIRF technique adds a new tool to our arsenal for studying the dynamics of biosensor interfaces.</p></div>","PeriodicalId":79341,"journal":{"name":"ImmunoMethods","volume":"3 2","pages":"Pages 104-111"},"PeriodicalIF":0.0,"publicationDate":"1993-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1006/immu.1993.1044","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51492095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Immunosensors: Principles and Applications","authors":"Vo-Dinh T., Sepaniak M.J., Griffin G.D., Alarie J.P.","doi":"10.1006/immu.1993.1042","DOIUrl":"10.1006/immu.1993.1042","url":null,"abstract":"<div><p>This paper presents an overview of the principles and applications of immunofluorescence spectroscopy in the development of antibody-based fiber-optic sensors. Special focus is devoted to antibody-based fiber-optic fluoroimmunosensors developed in our laboratories to detect important pollutants and biochemicals. The fiber-optic sensor utilizes antibodies covalently bound or encapsulated on the probe tip. The usefulness of fluoroimmunosensors for environmental and biomedical monitoring is discussed.</p></div>","PeriodicalId":79341,"journal":{"name":"ImmunoMethods","volume":"3 2","pages":"Pages 85-92"},"PeriodicalIF":0.0,"publicationDate":"1993-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1006/immu.1993.1042","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51492471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ImmunoMethodsPub Date : 1993-08-01Epub Date: 2002-05-25DOI: 10.1006/immu.1993.1036
Carman Julie A., Monroe John G.
{"title":"Approaches to the Dissection of Receptor-Mediated Signal Transduction Pathways","authors":"Carman Julie A., Monroe John G.","doi":"10.1006/immu.1993.1036","DOIUrl":"10.1006/immu.1993.1036","url":null,"abstract":"<div><p>Cytokines are powerful regulators of lymphocyte growth and development. Recent progress in isolating and cloning cytokine receptors has provided detailed knowledge about the structures of these proteins. However, the mechanisms by which these receptors transduce signals following ligand binding remain largely unknown. The conventional approach to defining a receptor-regulated signal transduction pathway has been to determine the membrane-proximal biochemical events and to use pharmacological mimics of these biochemical messengers. While this approach has provided detailed information about the early signaling events coupled to several receptor systems, evidence for a relationship between these early events to downstream nuclear and cellular responses is often circumstantial. Powerful genetic approaches now are amenable to dissecting receptor-initiated signal transduction pathways. Our primary focus here is to discuss these new experimental approaches in the context of cytokine receptors, although these approaches are applicable to any receptor system. These approaches rely on the identification of receptor-induced early response genes. These genes, once identified, can be used as tools for the identification of upstream components of the specific receptor-linked signal transduction pathway. After a brief introduction to receptor-mediated signaling, our discussion of experimental approaches begins in the nucleus, describing techniques for identifying cytokine-regulated genes. Following identification of regulated genes, we discuss techniques for isolating the proteins that activate these genes. Finally, approaches to determining how these proteins are regulated by second messenger systems are described.</p></div>","PeriodicalId":79341,"journal":{"name":"ImmunoMethods","volume":"3 1","pages":"Pages 23-33"},"PeriodicalIF":0.0,"publicationDate":"1993-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1006/immu.1993.1036","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51492323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ImmunoMethodsPub Date : 1993-08-01Epub Date: 2002-05-25DOI: 10.1006/immu.1993.1040
Clore G.Marius, Gronenborn Angela M.
{"title":"Structural Studies of InterIeukin-1β, Interleukin-4, and lnterleukin-8","authors":"Clore G.Marius, Gronenborn Angela M.","doi":"10.1006/immu.1993.1040","DOIUrl":"10.1006/immu.1993.1040","url":null,"abstract":"<div><p>In this review we present and discuss the structures of three cytokines, interleukin-1β, interleukin-4, and interleukin-8, in the solution and crystal states. The availability of these high-resolution structures provides a framework for understanding their mechanism of action, for relating structure to function, and for the rational design of potential agonists and antagonists</p></div>","PeriodicalId":79341,"journal":{"name":"ImmunoMethods","volume":"3 1","pages":"Pages 56-81"},"PeriodicalIF":0.0,"publicationDate":"1993-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1006/immu.1993.1040","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51492454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ImmunoMethodsPub Date : 1993-08-01Epub Date: 2002-05-25DOI: 10.1006/immu.1993.1038
Kossovsky Nir, Freiman Charles J., Stassi John B., Mena Edward
{"title":"Cytokine Expression in Response to Biomaterials","authors":"Kossovsky Nir, Freiman Charles J., Stassi John B., Mena Edward","doi":"10.1006/immu.1993.1038","DOIUrl":"10.1006/immu.1993.1038","url":null,"abstract":"<div><p>The biological consequences of implanting biomaterials can include a series of progressively more complex inflammatory reactions. Cytokines play a pivotal role in these reactions. Cytokines are divided into either proinflammatory or growth factors and their activity can affect the cell of their origin, have a localized effect, or induce a systemic response. The expression of interleukin-8, interleukin-1, interleukin-2, interleukin-6, and tumor necrosis factor can be affected by the presence of implanted materials, causing a change in the resulting inflammatory process and thus affecting the clinical performance of biomaterials or medical devices. <em>In vitro</em> and <em>in vivo</em> studies that show numerous widely used biomedical polymers eliciting cytokine production are reviewed.</p></div>","PeriodicalId":79341,"journal":{"name":"ImmunoMethods","volume":"3 1","pages":"Pages 43-49"},"PeriodicalIF":0.0,"publicationDate":"1993-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1006/immu.1993.1038","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51492419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ImmunoMethodsPub Date : 1993-08-01Epub Date: 2002-05-25DOI: 10.1006/immu.1993.1035
Hines Keith L., Christ Marielle, Wahl Sharon M.
{"title":"Cytokine Regulation of the Immune Response: An in Vivo Model","authors":"Hines Keith L., Christ Marielle, Wahl Sharon M.","doi":"10.1006/immu.1993.1035","DOIUrl":"10.1006/immu.1993.1035","url":null,"abstract":"<div><p>Cytokine interactions are central to the development of immune and inflammatory responses. While <em>in vitro</em> assays provide evidence about specific activities of individual cytokines, they are less informative concerning cytokine interactions that constitute the cytokine network. In this article we review an <em>in vivo</em> model of experimental inflammation, streptococcal cell wall (SCW)-induced arthritis in rats, which, when combined with <em>in vitro</em> analysis, provides a powerful approach to deciphering the complexity of the cytokine network. Using this model, it is possible to identify cytokines present in acute and chronic inflammatory lesions and their cells of origin, to administer these cytokines exogenously and monitor their impact, and to antagonize specific cytokine actions to establish a causal relationship. In this context, we have reviewed our experiences with one particular cytokine, transforming growth factor-β (TGF-β), which plays a key role in the regulation of immune and inflammatory events. Whereas systemically administered TGF-β attenuated SCW-induced joint inflammation, consistent with its known immunosuppressive activities, local (intra-articular) injection surprisingly exacerbated SCW-induced arthritis. Moreover, antagonism of TGF-β within the synovium with neutralizing antibodies impaired the development of inflammation as evaluated noninvasively by radiology and by the measurement of swelling, deformity, and erythema of individual joints. Additional parameters of analysis include histology to visualize tissue destruction, immunohistochemistry to detect the presence of specific cytokines or infiltrating immune cells, and Northern hybridization to measure the expression of cytokine mRNA. Thus, <em>in vivo</em> studies coupled with <em>in vitro</em> characterization provide a comprehensive biological and molecular profile of a particular cytokine and its place in the cytokine network. Moreover, this approach provides insight into potential mechanisms for therapeutic modulation of aberrant immune and inflammatory responses.</p></div>","PeriodicalId":79341,"journal":{"name":"ImmunoMethods","volume":"3 1","pages":"Pages 13-22"},"PeriodicalIF":0.0,"publicationDate":"1993-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1006/immu.1993.1035","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51492270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ImmunoMethodsPub Date : 1993-08-01Epub Date: 2002-05-25DOI: 10.1006/immu.1993.1034
Aarons Alan, Borish Larry
{"title":"Cytokines and Inflammation","authors":"Aarons Alan, Borish Larry","doi":"10.1006/immu.1993.1034","DOIUrl":"10.1006/immu.1993.1034","url":null,"abstract":"Abstract Virtually all of the cytokines mediate biological activities either directly on immune cells or upon the adhesion molecules with which immune cells interact and may therefore be considered pro-inflammatory. Several cytokines, including tumor necrosis factor (TNF), interleukin (IL)-1, IL-6, and members of the small cytokine family, are uniquely capable of promoting the cellular infiltrate and damage to resident tissue that are characteristic of inflammation. The biology and techniques for the assay of these cytokines are described. Bioassays provided the earliest methods available to characterize cytokines. While potentially more sensitive than immune-based assays, bioassays may not be able to distinguish between cytokines with cross-reacting activities. In addition, bioassays may be falsely negative in the face of inhibitors, It remains useful, however, to assay cytokines by their biological activity. ELISAs will not differentiate biologically active from inactive but immunoreactive forms of the proteins. Since bioassays will detect only functional activity, they may be useful for identifying cytokine antagonists in a reaction mixture. The molecular cloning of cytokine cDNAs and the development of large-scale expression methods have made available virtually unlimited quantities of protein for biological assays. Purified proteins have also been used to develop immune-based assay techniques such as ELISAs for quantifying cytokines. ELISAs provide the best and in many cases the only mechanism for distinguishing cytokines with significant overlapping biological activities. The isolation of cytokine-specific cDNAs permits the use of molecular techniques to identify cytokine-specific mRNA transcripts. An extremely sensitive technique for detecting transcripts is the RNA-based polymerase chain reaction (RT-PCR). Biological assays for IL-1, IL-6, IL-8, and TNF are well standardized and are described here. The general techniques for the ELISA and RT-PCR are also described.","PeriodicalId":79341,"journal":{"name":"ImmunoMethods","volume":"3 1","pages":"Pages 3-12"},"PeriodicalIF":0.0,"publicationDate":"1993-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1006/immu.1993.1034","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51492188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ImmunoMethodsPub Date : 1993-08-01Epub Date: 2002-05-25DOI: 10.1006/immu.1993.1039
Poli Guido, Kinter Audrey L., Justement Jesse S., Biswas Priscilla, Weissman Drew, Fox Lawrence M., Goletti Delia, Bressler Peter, Stanley Sharilyn K., Fauci Anthony S.
{"title":"The Chronically Infected Promonocytic Cell Line U1: A Model of HIV Expression Regulated by Cytokines","authors":"Poli Guido, Kinter Audrey L., Justement Jesse S., Biswas Priscilla, Weissman Drew, Fox Lawrence M., Goletti Delia, Bressler Peter, Stanley Sharilyn K., Fauci Anthony S.","doi":"10.1006/immu.1993.1039","DOIUrl":"10.1006/immu.1993.1039","url":null,"abstract":"<div><p>Infection with the human immunodeficiency virus (HIV) causes the acquired immunodeficiency syndrome (AIDS) over a medium period of 10 years. During this time cells that actively express HIV and cells that harbor the virus in a latent form have been demonstrated in different tissues and organs of infected individuals. It is critical to delineate the cellular and/or viral factors that regulate HIV expression and latency in order to fully understand the pathogenic mechanisms of HIV disease. Among several <em>in vitro</em> models that have been developed since HIV has been recognized as a human pathogen, the chronically infected promonocytic cell line U1 has become one of the more broadly used surrogate models for studies of immunologic and molecular regulation of HIV expression. In particular, more than 10 different cytokines have been shown to up- or down-regulate virus production in U1 cells either alone or in synergistic combination. Autocrine/paracrine induction of HIV expression was first demonstrated in this cell line, anticipating results in more complex models of virus infection. In addition to cytokines, hormones, vitamins, and physical and chemical agents, including UV light, heat, and reactive oxygen intermediates, have been shown to reactivate quiescent integrated proviruses. Finally, U1 cells have been used as standard controls for polymerase chain reaction studies, for pharmacologic screening of potentially therapeutic agents, and as a convenient multicytokine bioassay system for studies of immunologic control of HIV expression.</p></div>","PeriodicalId":79341,"journal":{"name":"ImmunoMethods","volume":"3 1","pages":"Pages 50-55"},"PeriodicalIF":0.0,"publicationDate":"1993-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1006/immu.1993.1039","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51492438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}